Assessment Of Cardiovascular Disease Risk with Type 2 Diabetes Mellitus At A Tertiary Care Hospital, Satkhira, Bangladesh

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) is increasing at pandemic rates, accompanied by a rapid increase in associated comorbidities such as cardiovascular disease (CVD). This problem is even more severe in South Asians, as the prevalence of T2DM and CVD is much higher in these populations, occurs at a younger age, and is associated with early onset and high mortality. Study Objective: The study objective was to determine the risk of cardiovascular disease in type 2 diabetes in a tertiary care hospital in Satkhira, Bangladesh. Methods & Materials: This observational cross-sectional study was conducted at the Faculty of Medicine and Hospital, Satkhira Medical College, Bangladesh. The study enrolled and analyzed 220 patients from March 2022 to February 2023. Result: A total 220 patients were enrolled and analyzed. Most of the patients were aged more than 60 years which is 45.91%, 62(28.18%) patients were from the age range 51-60 years, 44(20.00%) patients were from the age range 41-50 years, and 13(5.91%) patients were from the age range 31-40 years The mean and standard deviation of the biochemical parameters. In this study, we assess the study population's CVD risk factors. Following the risk reduction intervention, antihypertensive medications were majorly used in this study (74.09%); 99 (45.00%) patients used ACE inhibitors and 76(34.55%) patients used AT receptor blockage. Conclusion: Bangladeshi patients with diabetes showed a significant burden of CVD risk at a relatively younger age. Strategies for reducing tobacco use and improving BP control in people with diabetes are needed to lower future CVD risks.